Jpmorgan Chase & CO Mimedx Group, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MDXG
# of Institutions
209Shares Held
98.2MCall Options Held
8KPut Options Held
65.3K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$261 Million47.81% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$86.2 Million0.0% of portfolio
-
Trigran Investments, Inc.7.69MShares$71.1 Million4.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.97MShares$64.5 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.66MShares$43.1 Million1.25% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $1.05B
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...